Tri Locum Partners as of March 31, 2026
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 17 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | 14.2 | $101M | 415k | 244.44 | |
| Intuitive Surgical Com New (ISRG) | 9.9 | $71M | 153k | 460.99 | |
| Thermo Fisher Scientific (TMO) | 9.1 | $65M | 132k | 491.53 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 8.2 | $58M | 255k | 228.73 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 8.1 | $58M | 129k | 446.54 | |
| Eli Lilly & Co. (LLY) | 8.0 | $57M | 62k | 919.77 | |
| Madrigal Pharmaceuticals (MDGL) | 7.6 | $54M | 103k | 523.47 | |
| Dex (DXCM) | 6.2 | $44M | 698k | 62.80 | |
| United Therapeutics Corporation (UTHR) | 5.9 | $42M | 70k | 592.98 | |
| Nuvalent Inc-a (NUVL) | 4.4 | $32M | 309k | 102.45 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.3 | $31M | 1.0M | 30.12 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.2 | $30M | 159k | 189.05 | |
| Argenx Se Sponsored Adr (ARGX) | 3.2 | $23M | 32k | 730.25 | |
| Tarsus Pharmaceuticals (TARS) | 2.5 | $18M | 253k | 70.15 | |
| Dianthus Therapeutics (DNTH) | 1.7 | $12M | 146k | 83.92 | |
| Axsome Therapeutics (AXSM) | 1.5 | $11M | 62k | 169.02 | |
| Definium Therapeutics Com Shs (DFTX) | 1.0 | $7.0M | 370k | 18.90 |
